Drug for Ulcerative Colitis Is Focus of OASIS Clinical Trial

Drug for Ulcerative Colitis Is Focus of OASIS Clinical Trial
A new study being conducted in more than 100 clinical centers across the world is evaluating the safety and efficacy of a new investigational drug for the treatment of mild to severely active ulcerative colitis. The OASIS clinical trial aims to recruit 240 adults, ages 18 to 80 years old, who have been diagnosed with ulcerative colitis

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *